StepStone Group, Inc. Class A STEP 深 沪
已收盘 05-08 16:00:00 美东时间
55.74
+1.560
+2.88%
华盛通- 最 高55.76
- 今 开54.14
- 成交量 78.61万股
- 最 低 52.61
- 昨 收 54.18
- 总市值 66.42亿
- 52周最高 77.515
- 市盈率 静 --
- 换手率 0.66%
- 52周最低 40.58
- 委 比 -87.02%
- 总股本 1.19亿
- 历史最高 77.515
- 量 比 1.10
- 振 幅 5.81%
- 历史最低 16.19
- 每 手 1
- 风险率 7.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多StepStone Group And Morningstar Subsidiary PitchBook Announce Partnership To Provide Access To StepStone's Deal-Level Benchmarks Through PitchBook Platform
The offering is expected to be available in the second quarter of 2026 and will be offered to fund managers and service providers through the PitchBook platform as a standalone solution and to investors through SPI by
05-06 20:10
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
Evercore ISI Group Maintains Outperform on StepStone Group, Raises Price Target to $59
Evercore ISI Group analyst John Dunn maintains StepStone Group (NASDAQ:STEP) with a Outperform and raises the price target from $57 to $59.
04-21 20:53
美股大行评级 | 大摩上调哔哩哔哩目标价从25美元升至31美元；大砍近50%！汇丰下调耐克目标价从90美元降至48美元
今日重点评级关注：HC Wainwright & Co.：维持Solaris Resources"买入"评级，目标价从16美元升至18美元；Leerink Partners：维持Spyre Therapeutics"跑赢大市"评级，目标价从49美元升至106美元
04-14 10:44
Oppenheimer Maintains Outperform on StepStone Group, Lowers Price Target to $90
Oppenheimer analyst Chris Kotowski maintains StepStone Group (NASDAQ:STEP) with a Outperform and lowers the price target from $104 to $90.
04-14 00:44
美股大行评级 | 瑞银上调美光科技目标价从510升至535美元；巴克莱下调Robinhood 目标价从124降至89美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5美元升至5.25美元；Benchmark：维持Direct Digital Holdings"投机性买入"评级，目标价从2美元升至8美元
04-09 10:15
美股大行评级 | 摩根大通上调霸王茶姬至"超配"，目标价上调至16美元；康尼格拉食品遭高盛、瑞银等7家机构下调目标价
今日重点评级关注：Leerink Partners：维持Camp4 Therapeutics"跑赢大市"评级，目标价从8美元升至9美元；韦德布什：维持Arcus Biosciences"跑赢大市"评级，目标价从37美元升至41美元
04-06 16:27
UBS Assumes StepStone Group at Buy, Announces Price Target of $60
UBS analyst Michael Brown assumes StepStone Group (NASDAQ:STEP) with a Buy rating and announces Price Target of $60.
04-03 01:00
美股大行评级 | 潜在涨幅499.25%！Cabaletta Bio获Guggenheim升目标价至16美元，维持"买入"评级
今日重点评级关注：Guggenheim：维持Cabaletta Bio"买入"评级，目标价从15美元升至16美元；HC Wainwright & Co.：维持Palvella Therapeutics"买入"评级，目标价从255美元升至270美元
03-25 10:31
BMO Capital Maintains Outperform on StepStone Group, Lowers Price Target to $58
BMO Capital analyst Brennan Hawken maintains StepStone Group (NASDAQ:STEP) with a Outperform and lowers the price target from $70 to $58.
03-25 01:49
